DNA damage, somatic aneuploidy, and malignant sarcoma susceptibility in muscular dystrophies.
about
Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapyAtypical Lipomatous Tumor/Well-Differentiated Liposarcoma Developed in a Patient with Progressive Muscular Dystrophy: A Case Report and Review of the LiteratureForelimb treatment in a large cohort of dystrophic dogs supports delivery of a recombinant AAV for exon skipping in Duchenne patients.Dystrophin is a tumor suppressor in human cancers with myogenic programs.Human intellectual disability genes form conserved functional modules in Drosophila.The FVB Background Does Not Dramatically Alter the Dystrophic Phenotype of Mdx MiceShort-lived recombinant adeno-associated virus transgene expression in dystrophic muscle is associated with oxidative damage to transgene mRNA.MURC/cavin-4 Is Co-Expressed with Caveolin-3 in Rhabdomyosarcoma Tumors and Its Silencing Prevents Myogenic Differentiation in the Human Embryonal RD Cell Line.Dystrophin and dysferlin double mutant mice: a novel model for rhabdomyosarcomaAggressiveness of human melanoma xenograft models is promoted by aneuploidy-driven gene expression deregulationProbing for a deeper understanding of rhabdomyosarcoma: insights from complementary model systems.Induction of a regenerative microenvironment in skeletal muscle is sufficient to induce embryonal rhabdomyosarcoma in p53-deficient miceDNA damage-activated ABL-MyoD signaling contributes to DNA repair in skeletal myoblasts.Cancer-related genes in the transcription signature of facioscapulohumeral dystrophy myoblasts and myotubes.Non-myogenic tumors display altered expression of dystrophin (DMD) and a high frequency of genetic alterations.Hip region muscular dystrophy and emergence of motor deficits in dysferlin-deficient Bla/J mice.Genetic polymorphisms associated with pancreatic cancer survival: a genome-wide association study.Control of DNA integrity in skeletal muscle under physiological and pathological conditions.Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma.A urinary microRNA signature can predict the presence of bladder urothelial carcinoma in patients undergoing surveillance.Distinct responses to reduplicated chromosomes require distinct Mad2 responses.Distinct effects of contraction-induced injury in vivo on four different murine models of dysferlinopathy.Increased FSHD region gene1 expression reduces in vitro cell migration, invasion, and angiogenesis, ex vivo supported by reduced expression in tumors.Synchrony in stochastically driven neuronal networks with complex topologies.Facioscapulohumeral dystrophy myoblasts efficiently repair moderate levels of oxidative DNA damage.Polyteny: still a giant player in chromosome research.Targeting muscle stem cell intrinsic defects to treat Duchenne muscular dystrophy.
P2860
Q28084979-A72EC6A1-2B8A-468D-B14B-1BB6C34009E1Q33786885-9E46C05C-2818-4623-97D7-EF440A446A3CQ34041966-174F2329-15B0-4837-B60F-C3279C5E93D2Q34479070-4D2EA1B9-B949-4EED-AC14-6A082EBBC7E6Q35034366-830B18B7-89AF-43DF-B0C8-A4D240BAE907Q35117470-34D3FC38-BC49-42CE-9564-16B2370F83E2Q35651108-6AD49493-73AC-41F4-A01A-2F4E9F2761BEQ35667137-882BE510-E10C-4D5D-B367-90A408ECA3C0Q36025454-2478AB33-A776-43C3-A31E-F5A5A4894B3DQ36050683-408550BF-E155-4BEB-BD7E-110D74CD9543Q36142754-D9BF1EAD-D009-4AB1-857E-61DA4F561830Q36503375-C463B224-B1B5-4F6A-A467-0162100EC587Q37299454-6DDEC2C8-74F7-4977-8553-7B9745B4B945Q37595289-E32DA754-C522-4F2D-8560-73489FAE3EE2Q37702112-36D75BCD-0DDF-4B9C-A36E-A97E47E2DEE8Q37727394-FFE71CAE-FCF6-441D-BAC4-03DA5862CC66Q38805564-C49F8509-D8CD-4460-912B-63622B9D4CA0Q38819181-FE4DF744-B75B-4777-8E81-FB5D17064ACFQ38893243-3DE5420C-9B2C-4F89-9674-51D3962C9AEBQ39734525-95246DA9-E179-4FE6-A48E-BCA11291DF3DQ42038052-4595696D-9A84-4A04-B9AB-4A7C37410239Q42129224-E040DAE9-707E-4B5C-82BD-DA8B5CDEC9EEQ47119855-BBA026D4-2705-4BA3-A967-3CA6D522B2B8Q47729139-2999ABD1-571A-4CA1-A773-497006D2BD4FQ48243281-CBB34129-2800-4F09-B625-BC200E04D45AQ53738637-9ABF3BBE-8726-4479-BCB3-C0ECE41628C8Q55063443-6B4A1C1C-B0D4-4BD5-AF29-129CF31E07B3
P2860
DNA damage, somatic aneuploidy, and malignant sarcoma susceptibility in muscular dystrophies.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
DNA damage, somatic aneuploidy ...... ility in muscular dystrophies.
@ast
DNA damage, somatic aneuploidy ...... ility in muscular dystrophies.
@en
type
label
DNA damage, somatic aneuploidy ...... ility in muscular dystrophies.
@ast
DNA damage, somatic aneuploidy ...... ility in muscular dystrophies.
@en
prefLabel
DNA damage, somatic aneuploidy ...... ility in muscular dystrophies.
@ast
DNA damage, somatic aneuploidy ...... ility in muscular dystrophies.
@en
P2093
P2860
P50
P1433
P1476
DNA damage, somatic aneuploidy ...... ility in muscular dystrophies.
@en
P2093
Harald Höger
Inge M Ambros
Karin Moser-Thier
Mohammed H Uddin
Reginald E Bittner
Sandra Dysek
P2860
P304
P356
10.1371/JOURNAL.PGEN.1002042
P577
2011-04-14T00:00:00Z